CVS Health Corp vs Lam Research Corporation — how do they compare? CVS Health Corp trades at $93.57 (market cap $119.58B), while Lam Research Corporation trades at $320.8 (market cap $389.67B). The key difference: Lam Research Corporation is far larger — about 3.3× CVS Health Corp's market cap, and CVS Health Corp pays the higher dividend (2.84%). Which is the better fit depends on your goals.
| CVS | LRCX | |
|---|---|---|
Market Cap | $119.58B | $389.67B |
Sector | Health | Technology |
52-Week High | $110.60 | $433.33 |
52-Week Low | $65.51 | $97.03 |
Enterprise Value | $181.93B | $387.83B |
Dividend Yield | 2.84% | 0.33% |
Trailing returns across standard periods
Latest headlines on both assets
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →Lam Research manufactures equipment used to fabricate semiconductors. The firm is focused on the etching, deposition, and clean markets, which are key steps in the semiconductor manufacturing process, especially for 3D NAND flash storage, advanced DRAM, and leading-edge logic/foundry chipmakers. Lam's flagship Kiyo, Vector, and Sabre products are sold in all major geographies to key customers such as Samsung Electronics, Micron, Intel, and Taiwan Semiconductor Manufacturing.
Read more on LRCX →